Budesonide Multimatrix (MMX)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Budesonide Multimatrix (MMX), covering 2022-04-22 to 2022-04-22. Get the full timeline:
Most recent: Clinical Trial Update: Budesonide Multimatrix(MMX) Versus Prednisolone in Management of Mild to Moderate Ulcerative Colitis [Phase 2, Phase 3]